McGowan IM, Chawki S, Hendrix CW, Anton PA, et al. A Randomized, Open Label, Crossover Phase 1 Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel (the CHARM-03 Study). AIDS Res Hum Retroviruses 2021 Aug 12. doi: 10.1089/AID.2021.0096.
PMID: 34384282